false
0000835662
0000835662
2026-01-26
2026-01-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (date of earliest event reported): January 26, 2026

AIXIN
LIFE INTERNATIONAL, INC.
(Exact
name of registrant as specified in its charter)
| Colorado |
|
0-17284 |
|
84-1085935 |
| State
of |
|
Commission |
|
IRS
Employer |
| Incorporation |
|
|
|
Identification
No. |
Hongxing
International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District
Chengdu
City, Sichuan Province, China
(Address
of principal executive offices)
610021
86-313-6732526
(Issuer’s
telephone number)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock |
|
AIXN |
|
OTCQB |
| Item
5.02 |
Departure
of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On
January 27, 2026, the Company’s Board of Directors accepted the resignation of Mr. Yao-te Wang from his position as a director
of the Company effective January 26, 2026. Concurrent with the acceptance of Mr. Wang’s resignation from the Board of Directors
of the Company, he was removed from all officer positions held in the Company or any of its subsidiaries.
| Item
9.01 |
Financial
Statements and Exhibits. |
| Exhibit
No. |
|
Description |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
AiXin
Life International, Inc. |
| |
|
|
| Date:
January 28, 2026 |
By: |
/s/
Quanzhong Lin |
| |
|
Quanzhong
Lin |
| |
|
Chief
Executive Officer |